Crop Production in Switzerland- Hemp/Cannabis

ByCédric Heeb
From 01.01.2021, the following applies:

  • The agricultural production of hemp is allowed, provided it isn’t classified as a narcotic. All provisions of the seed legislation relating to the production and sale of hemp seed and seedlings are repealed (set of regulations 2020).
  • For the agricultural production of hemp, the provisions of the plant health legislation and the direct payments legislation must be respected.
  • For the use of hemp as animal feed, the provisions of the animal feed legislation must be respected.
Categories of use
Category Crop THC* Use Legal base Competence
recreational Cannabis flower > 1% other than medicinal NarcA FOPH
medical Cannabis flower > 1% medicinal NarcA

TPA

 FOPH
CBD-hemp flower < 1% medicinal /

industrial

 TPA /

other

 casewise delimination
oil and fibre hemp seed, shoot < 1% industrial AgricA FOAG

*narcotic substance tetrahydrocannabinol

Information from the Federal Office of Public Health – Cannabis as narcotic

Information from the Federal Office of Public Health – Cannabis cultivation

Information from the Swiss Agency for Therapeutic Products – Questions on delimitation / Products containing cannabidiol

Information from Agroscope – Alternative crops

Information from Agroscope – Hemp as animal feed

Swiss Association for seed trade and plant breeders’ rights – Information from seed trade and distribution partners

https://www.blw.admin.ch/blw/en/home/nachhaltige-produktion/pflanzliche-produktion/hanf.html

Similar Posts

Cannabinoids in the Treatment of Epilepsy
|

Cannabinoids in the Treatment of Epilepsy

ByNikola NOWOTARSKA

Epilepsy is one of the most common non-transmissible neurological diseases. It is defined as a brain disorder that predisposes to seizures and has associated physical, psychological and social consequences. Approximately one-third of patients with epilepsy have seizures that are resistant to antiepileptic medications. These patients do not respond well to the conventional antiepileptic drugs. Moreover,…

Medical cannabis available by prescription
|

Medical cannabis available by prescription

ByCédric Heeb

Starting this summer, it will be easier to get a prescription for medical cannabis. But watch your wallet, because it won’t be automatically reimbursed. Cannabis-based medicines will soon be available by prescription, without the need for exceptional authorization from the Federal Office of Public Health (FOPH). This legislative change will probably come into force in…

Access to medicinal cannabis for patients to be simplified
|

Access to medicinal cannabis for patients to be simplified

ByCédric Heeb

Access to medicinal cannabis for patients to be simplified Bern, 22.06.2022 – The Federal Council wants to make it easier for patients to access medicinal cannabis. It therefore decided at its meeting on June 22 to lift the ban on cannabis for medicinal purposes from the Narcotics Act. Medical prescriptions no longer require an exceptional…

Products containing cannabidiol (CBD) – overview 21.04.2021 updates

Products containing cannabidiol (CBD) – overview 21.04.2021 updates

ByCédric Heeb

Implementation guide by the technical platform for delimitation issues of the FOPH, the FSVO and Swissmedic Products containing cannabidiol (CBD) are gaining popularity in Switzerland. Unlike THC (tetrahydrocannabinol), CBD is not subject to the Narcotics Act because it does not produce a comparable psychoactive effect. However, this does not mean that CBD can simply be…

Medical Cannabis & Cannabinoid Regulation 2021

Medical Cannabis & Cannabinoid Regulation 2021

ByCédric Heeb

Trends and Developments The current regulatory environment surrounding cannabinoid-based products in Switzerland is unfortunately still marked by a high degree of uncertainty, due both to vague legislative requirements and heterogenous, sometimes arbitrary, enforcement. However, with the rise of public awareness of the general benefits of the cannabis plant as a result of the cannabidiol (CBD)…

Implementing ordinance for facilitated access to treatments with medicinal cannabis in the consultation process
|

Implementing ordinance for facilitated access to treatments with medicinal cannabis in the consultation process

ByCédric Heeb

Bern, 25.08.2021 – At its meeting on August 25, 2021, the Federal Council opened the consultation on the implementation of the amendment to the Narcotics Act (BetmG) passed by Parliament. The amendment is intended to facilitate access to treatments with therapeutic cannabis. In the future, a prescription will no longer require the granting of an exceptional authorization from the Federal Office of Public Health (FOPH). Cannabis for consumption purposes, on the other hand, will continue to be prohibited.